Topical Treatment of Actinic Keratoses with Piroxicam 1% GelA Preliminary Open-Label Study Utilizing a New Clinical Score

被引：0
|
作者：
Elena Campione
Laura Diluvio
Evelin Jasmine Paternò
Sergio Chimenti
机构：
[1] University of Rome “Tor Vergata”,Department of Dermatology
来源：
American Journal of Clinical Dermatology | 2010年 / 11卷
关键词：
Hyaluronic Acid; Piroxicam; Imiquimod; Actinic Keratose; Etretinate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The cyclo-oxygenase enzymes 1 and 2 (COX-1 and COX-2) are both involved in skin tumorigenesis, causing inhibition of apoptosis, angiogenesis, invasiveness, recruitment of growth factors, immunosuppression, and production of carcinogens. Piroxicam is a nonselective nonsteroidal anti-inflammatory drug that blocks the activity of COX-1 and COX-2.
引用
收藏
页码：45 / 50
页数：5
相关论文
共 50 条
  • [21] An open-label clinical study of nitazoxanide in the treatment of human fascioliasis
    Kabil, SM
    El Ashry, E
    Ashraf, NK
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (06): : 339 - 345
  • [22] An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses
    Rivers, JK
    McLean, DI
    ARCHIVES OF DERMATOLOGY, 1997, 133 (10) : 1239 - 1242
  • [23] Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses
    Campione, Elena
    Rivieccio, Antonia
    Shumak, Ruslana Gaeta
    Costanza, Gaetana
    Cosio, Terenzio
    Lambiase, Sara
    Garofalo, Virginia
    Artosi, Fabio
    Lozzi, Flavia
    Freni, Claudia
    Romeo, Alice
    Dika, Emi
    Falconi, Mattia
    Bianchi, Luca
    PHARMACEUTICALS, 2023, 16 (12)
  • [24] Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: An initial clinical study
    Szeimies, RM
    Karrer, S
    Sauerwald, A
    Landthaler, M
    DERMATOLOGY, 1996, 192 (03) : 246 - 251
  • [25] Topical 1% propranolol ointment with occlusion in treatment of pyogenic granulomas: An open-label study in 22 children
    Neri, Iria
    Baraldi, Carlotta
    Balestri, Riccardo
    Piraccini, Bianca Maria
    Patrizi, Annalisa
    PEDIATRIC DERMATOLOGY, 2018, 35 (01) : 117 - 120
  • [26] An Open-Label Clinical Study on the Efficacy of Melatonin Prophylaxis in Migraine: A Preliminary Report
    Karadas, Omer
    Odabasi, Zeki
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (01): : 44 - 47
  • [27] Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head
    Rivers, Jason K.
    Rosoph, Les
    Provost, Nathalie
    Bissonnette, Robert
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2008, 12 (03) : 97 - 101
  • [28] A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients
    Anand, A
    Bukhari, L
    Jennings, SA
    Lee, C
    Kamat, M
    Shekhar, A
    Nurnberger, JI
    Lightfoot, J
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (02) : 195 - 198
  • [29] Topical Pimecrolimus 1% Cream for Resistant Seborrheic Dermatitis of the FaceAn Open-Label Study
    Muge Guler Ozden
    Nilgun Solak Tekin
    Nilsel İlter
    Handan Ankarali
    American Journal of Clinical Dermatology, 2010, 11 : 51 - 54
  • [30] Topical Pimecrolimus 1% Cream for Resistant Seborrheic Dermatitis of the Face An Open-Label Study
    Ozden, Muge Guler
    Tekin, Nilgun Solak
    Ilter, Nilsel
    Ankarali, Handan
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2010, 11 (01) : 51 - 54
12345